Author Index

Search or browse for an author across our entire electronic archive

Search results for: H
Results 71 - 80 of 1849 shown below

  • Habrand, J-L

    E Lacaze, V Kieffer, A Streri, C Lorenzi, E Gentaz, J-L Habrand, G Dellatolas, C Kalifa and J Grill

    Neuropsychological outcome in children with optic pathway tumours when first-line treatment is chemotherapy

    doi:10.1038/sj.bjc.6601410

    Abstract | Full article | PDF

  • V Minard-Colin, C Kalifa, J-M Guinebretiere, L Brugieres, J Dubousset, J-L Habrand, G Vassal and O Hartmann

    Outcome of flat bone sarcomas (other than Ewing's) in children and adolescents: a study of 25 cases

    doi:10.1038/sj.bjc.6601564

    Abstract | Full article | PDF

  • Habu, S

    M Senoo, I Tsuchiya, Y Matsumura, T Mori, Y Saito, H Kato, T Okamoto and S Habu

    Transcriptional dysregulation of the p73L / p63 / p51 / p40 / KET gene in human squamous cell carcinomas: expression of Delta Np73L, a novel dominant-negative isoform, and loss of expression of the potential tumou

    doi:10.1054/bjoc.2000.1735

    Abstract | Full article | PDF

  • Habuchi, T

    J S Aveyard, A Skilleter, T Habuchi and M A Knowles

    Somatic mutation of PTEN in bladder carcinoma

    doi:10.1038/sj.bjc.6690439

    Abstract | Full article | PDF

  • Hachisuga, T

    T Hachisuga, H Tsujioka, S Horiuchi, T Udou, M Emoto and T Kawarabayashi

    K-ras mutation in the endometrium of tamoxifen-treated breast cancer patients, with a comparison of tamoxifen and toremifene

    advance online publication, 2005-03-08 00:00:00.000;

    doi:10.1038/sj.bjc.6602456

    Abstract | Full article | PDF

  • Hack, R

    M Fiegl, A Massoner, M Haun, W Sturm, H Kaufmann, R Hack, J Krugmann, M Fritzer-Szekeres, K Grünewald and G Gastl

    Sensitive detection of tumour cells in effusions by combining cytology and fluorescence in situ hybridisation (FISH)

    advance online publication, 2004-06-29 00:00:00.000;

    doi:10.1038/sj.bjc.6601942

    Abstract | Full article | PDF

  • Hack, V

    R Breitkreutz, A Babylon, V Hack, K Schuster, M Tokus, H Böhles, E Hagmüller, L Edler and E Holm

    Effect of carnitine on muscular glutamate uptake and intramuscular glutathione in malignant diseases

    doi:10.1054/bjoc.1999.0933

    Abstract | Full article | PDF

  • Hacker, N F

    V A Heinzelmann-Schwarz, M Gardiner-Garden, S M Henshall, J P Scurry, R A Scolyer, A N Smith, A Bali, P Vanden Bergh, S Baron-Hay, C Scott, D Fink, N F Hacker, R L Sutherland and P M O'Brien

    A distinct molecular profile associated with mucinous epithelial ovarian cancer

    advance online publication, 2006-02-28 00:00:00.000;

    doi:10.1038/sj.bjc.6603003

    Abstract | Full article | PDF

  • P M O'Brien, M J Davies, J P Scurry, A N Smith, C A Barton, M J Henderson, D N Saunders, B S Gloss, K I Patterson, J L Clancy, V A Heinzelmann-Schwarz, R A Scolyer, Y Zeng, E D Williams, L Scurr, A DeFazio, D I Quinn, C K W Watts, N F Hacker, S M Henshall and R L Sutherland

    The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro

    advance online publication, 2008-03-18 00:00:00.000;

    doi:10.1038/sj.bjc.6604281

    Abstract | Full article | PDF

  • P M O'Brien, M J Davies, J P Scurry, A N Smith, C A Barton, M J Henderson, D N Saunders, B S Gloss, K I Patterson, J L Clancy, V A Heinzelmann-Schwarz, R Murali, R A Scolyer, Y Zeng, E D Williams, L Scurr, A DeFazio, Di Quinn, C K W Watts, N F Hacker, S M Henshall and R L Sutherland

    The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro

    doi:10.1038/sj.bjc.6604419

    Abstract | Full article | PDF

  • C A Barton, B S Gloss, W Qu, A L Statham, N F Hacker, R L Sutherland, S J Clark and P M O'Brien

    Collagen and calcium-binding EGF domains 1 is frequently inactivated in ovarian cancer by aberrant promoter hypermethylation and modulates cell migration and survival

    advance online publication, 2009-11-24 00:00:00.000;

    doi:10.1038/sj.bjc.6605429

    Abstract | Full article | PDF

  • D M Purdie, C J Bain, V Siskind, P Russell, N F Hacker, B G Ward, M A Quinn and A C Green

    Hormone replacement therapy and risk of epithelial ovarian cancer

    doi:10.1038/sj.bjc.6690731

    Abstract | Full article | PDF

  • Hackett, C

    F A Olopade, A Norman, P Blake, D P Dearnaley, K J Harrington, V Khoo, D Tait, C Hackett and H J N Andreyev

    A modified Inflammatory Bowel Disease questionnaire and the Vaizey Incontinence questionnaire are simple ways to identify patients with significant gastrointestinal symptoms after pelvic radiotherapy

    advance online publication, 2005-04-26 00:00:00.000;

    doi:10.1038/sj.bjc.6602552

    Abstract | Full article | PDF

  • Hackett, S

    J S Waters, C Moss, L Pyle, M James, S Hackett, R A'Hern, M Gore and T Eisen

    Phase II clinical trial of capecitabine and gemcitabine chemotherapy in patients with metastatic renal carcinoma

    advance online publication, 2004-10-26 00:00:00.000;

    doi:10.1038/sj.bjc.6602209

    Abstract | Full article | PDF

  • T Eisen, T Ahmad, K T Flaherty, M Gore, S Kaye, R Marais, I Gibbens, S Hackett, M James, L M Schuchter, K L Nathanson, C Xia, R Simantov, B Schwartz, M Poulin-Costello, P J O'Dwyer and M J Ratain

    Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis

    advance online publication, 2006-08-01 00:00:00.000;

    doi:10.1038/sj.bjc.6603291

    Abstract | Full article | PDF

  • Hackman, J

    B Stea, E Shaw, T Pintér, J Hackman, M Craig, J May, R P Steffen and J H Suh

    Efaproxiral red blood cell concentration predicts efficacy in patients with brain metastases

    doi:10.1038/sj.bjc.6603169

    Abstract | Full article | PDF